Literature DB >> 18765895

The three-dimensional cultivation of the carcinoma cell line HepG2 in a perfused chip system leads to a more differentiated phenotype of the cells compared to monolayer culture.

B Altmann1, S Giselbrecht, K-F Weibezahn, A Welle, E Gottwald.   

Abstract

We describe a polymer chip with a grid-like architecture that it is intended for the three-dimensional cultivation of cells with an active nutrient and gas supply. The chip is typically made from polymethyl methacrylate or polycarbonate but can also be manufactured from biodegradable polymers, such as poly(lactic-co-glycolic acid). Different designs of the chip can be realized. In this study, we evaluated a chip with 506 microcontainers of the size of 300 x 300 x 300 microm that are capable of housing up to 6 million cells, and its suitability as a tissue-specific culture system for the carcinoma cell line HepG2 instead of primary liver cells. Related to an earlier study, where we could show the principal suitability of the system for rat primary cells, we here investigated the system's suitability for the human carcinoma cell line HepG2. The carcinoma cells were used in two different types of chip-containing bioreactors. By confocal laser scanning microscopy, we could show that cellular integrity in the chip culture was maintained and that there were no signs of apoptosis as confirmed by the absence of K18 fragmentation. Gene expression analysis of some liver-specific genes revealed a significantly higher expression of the phase II metabolism genes uridine-diphosphate- glucosyl-transferase (UGT1A1) and glutathione-S-transferase (GSTpi1) as a marker. Therefore, we conclude that by using a three-dimensional instead of a conventional monolayer culture system, hepatocellular carcinoma cells display a phenotype that resembles more closely the tissue of origin.

Entities:  

Mesh:

Year:  2008        PMID: 18765895     DOI: 10.1088/1748-6041/3/3/034120

Source DB:  PubMed          Journal:  Biomed Mater        ISSN: 1748-6041            Impact factor:   3.715


  7 in total

1.  Influence of a three-dimensional, microarray environment on human cell culture in drug screening systems.

Authors:  Luciana Meli; Eric T Jordan; Douglas S Clark; Robert J Linhardt; Jonathan S Dordick
Journal:  Biomaterials       Date:  2012-09-19       Impact factor: 12.479

2.  Real-time in situ viability assessment in a 3D bioreactor with liver cells using resazurin assay.

Authors:  Daniel Mueller; Georg Tascher; Georg Damm; Andreas K Nüssler; Elmar Heinzle; Fozia Noor
Journal:  Cytotechnology       Date:  2012-07-25       Impact factor: 2.058

3.  Automated Analysis of Acetaminophen Toxicity on 3D HepaRG Cell Culture in Microbioreactor.

Authors:  Martin Baca; Dana Brauer; Maren Klett; Uta Fernekorn; Sukhdeep Singh; Jörg Hampl; G Alexander Groß; Patrick Mai; Karin Friedel; Andreas Schober
Journal:  Bioengineering (Basel)       Date:  2022-05-02

Review 4.  High Content Imaging (HCI) on Miniaturized Three-Dimensional (3D) Cell Cultures.

Authors:  Pranav Joshi; Moo-Yeal Lee
Journal:  Biosensors (Basel)       Date:  2015-12-14

Review 5.  3D Cultivation Techniques for Primary Human Hepatocytes.

Authors:  Anastasia Bachmann; Matthias Moll; Eric Gottwald; Cordula Nies; Roman Zantl; Helga Wagner; Britta Burkhardt; Juan J Martínez Sánchez; Ruth Ladurner; Wolfgang Thasler; Georg Damm; Andreas K Nussler
Journal:  Microarrays (Basel)       Date:  2015-02-16

6.  Tracking protein function with sodium multi quantum spectroscopy in a 3D-tissue culture based on microcavity arrays.

Authors:  Andreas Neubauer; Cordula Nies; Victor D Schepkin; Ruomin Hu; Matthias Malzacher; Jorge Chacón-Caldera; David Thiele; Eric Gottwald; Lothar R Schad
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

7.  The cellular heat shock response monitored by chemical exchange saturation transfer MRI.

Authors:  Dennis Kleimaier; Steffen Goerke; Cordula Nies; Moritz Zaiss; Patrick Kunz; Peter Bachert; Mark E Ladd; Eric Gottwald; Lothar R Schad
Journal:  Sci Rep       Date:  2020-07-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.